Core Laboratories (NYSE:CLB) Announces Earnings Results

Core Laboratories (NYSE:CLBGet Free Report) posted its quarterly earnings results on Wednesday. The oil and gas company reported $0.23 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.23, Zacks reports. Core Laboratories had a net margin of 5.99% and a return on equity of 16.43%. Core Laboratories updated its Q1 2025 guidance to 0.120-0.160 EPS.

Core Laboratories Price Performance

Core Laboratories stock traded down $0.48 during trading hours on Friday, hitting $17.28. 55,322 shares of the stock were exchanged, compared to its average volume of 283,060. The stock has a market capitalization of $811.06 million, a P/E ratio of 26.18, a P/E/G ratio of 1.09 and a beta of 2.39. The business’s 50-day moving average is $18.94 and its two-hundred day moving average is $19.48. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $25.13.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Monday, February 10th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.23%. The ex-dividend date is Monday, February 10th. Core Laboratories’s dividend payout ratio is currently 6.06%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CLB shares. Citigroup lowered their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.00.

View Our Latest Stock Analysis on CLB

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Further Reading

Earnings History for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.